Pacific Biosciences of California (PACB) Short Interest Ratio & Short Volume → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free PACB Stock Alerts $1.47 +0.09 (+6.52%) (As of 04/26/2024 08:53 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Pacific Biosciences of California Short Interest DataCurrent Short Volume48,520,000 sharesPrevious Short Volume49,050,000 sharesChange Vs. Previous Month-1.08%Dollar Volume Sold Short$137.55 millionShort Interest Ratio / Days to Cover5.0Last Record DateApril 15, 2024Outstanding Shares267,950,000 sharesPercentage of Shares Shorted18.11%Today's Trading Volume7,986,900 sharesAverage Trading Volume9,825,421 sharesToday's Volume Vs. Average81% Short Selling Pacific Biosciences of California ? Sign up to receive the latest short interest report for Pacific Biosciences of California and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPACB Short Interest Over TimePACB Days to Cover Over TimePACB Percentage of Float Shorted Over Time Ad Investing DailyHis win rate puts Warren Buffett to shame… Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. Pacific Biosciences of California Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202448,520,000 shares $137.55 million -1.1%N/A5 $2.84 3/31/202449,050,000 shares $183.94 million +7.6%N/A5.6 $3.75 3/15/202445,570,000 shares $172.71 million +4.7%N/A5.4 $3.79 2/29/202443,540,000 shares $240.78 million +7.8%N/A5.3 $5.53 2/15/202440,380,000 shares $269.33 million +18.1%N/A5.4 $6.67 1/31/202434,190,000 shares $222.58 million -5.0%N/A5.1 $6.51 Get the Latest News and Ratings for PACB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pacific Biosciences of California and its competitors with MarketBeat's FREE daily newsletter. 1/15/202436,000,000 shares $241.56 million -4.7%N/A5.6 $6.71 12/31/202337,780,000 shares $370.62 million +8.3%N/A6.7 $9.81 12/15/202334,890,000 shares $329.36 million +4.4%N/A6.7 $9.44 11/30/202333,430,000 shares $283.49 million -14.8%N/A7 $8.48 11/15/202339,230,000 shares $306.39 million +11.7%N/A8.5 $7.81 10/31/202335,120,000 shares $217.04 million -6.9%N/A8.1 $6.18 10/15/202337,740,000 shares $301.17 million +14.1%N/A9.6 $7.98 9/30/202333,070,000 shares $276.13 million -2.2%N/A8.6 $8.35 9/15/202333,820,000 shares $352.40 million +2.3%N/A9.4 $10.42 8/31/202333,060,000 shares $372.92 million +5.3%N/A9.3 $11.28 8/15/202331,390,000 shares $352.20 million +10.6%N/A8.3 $11.22 7/31/202328,390,000 shares $375.03 million -7.6%N/A7.7 $13.21 7/15/202330,710,000 shares $421.96 million -2.7%N/A8.6 $13.74 6/30/202331,550,000 shares $419.62 million +25.3%N/A8.8 $13.30 6/15/202325,190,000 shares $335.28 million -1.0%N/A6.7 $13.31 5/31/202325,440,000 shares $314.95 million +5.2%N/A6.7 $12.38 5/15/202324,180,000 shares $300.80 million -5.0%N/A6.6 $12.44 4/30/202325,440,000 shares $269.66 million -6.4%N/A6.7 $10.60 4/15/202327,180,000 shares $304.42 million +8.3%N/A6.6 $11.20 3/31/202325,100,000 shares $290.66 million -4.5%N/A5.8 $11.58 3/15/202326,280,000 shares $238.10 million +14.2%N/A6.2 $9.06 2/28/202323,020,000 shares $209.02 million +8.4%N/A5.6 $9.08 2/15/202321,240,000 shares $235.55 million -5.6%N/A5.3 $11.09 1/31/202322,490,000 shares $249.41 million -7.1%N/A5 $11.09 1/15/202324,200,000 shares $265.23 million -1.9%N/A4.9 $10.96 12/30/202224,670,000 shares $201.80 million +8.1%N/A5.1 $8.18 12/15/202222,820,000 shares $206.75 million +3.8%N/A4.4 $9.06 11/30/202221,990,000 shares $236.39 million -9.1%N/A3.9 $10.75 11/15/202224,190,000 shares $270.93 million +4.1%N/A4 $11.20 10/31/202223,240,000 shares $196.15 million -3.0%N/A3 $8.44 10/15/202223,950,000 shares $146.10 million -5.3%N/A3.1 $6.10 9/30/202225,290,000 shares $146.81 million -16.6%N/A3.3 $5.81 9/15/202230,310,000 shares $200.35 million +4.8%N/A3.8 $6.61 8/31/202228,930,000 shares $169.53 million -11.6%N/A3.6 $5.86His win rate puts Warren Buffett to shame… (Ad)Not long ago I joined Phil Ash for a private one-on-one interview. And during our time together I pulled the covers of my investing system that’s delivered 779 winners and 43,509% total profits since November of 2015… Without a single loss.Click here now for the full story. PACB Short Interest - Frequently Asked Questions What is Pacific Biosciences of California's current short interest? Short interest is the volume of Pacific Biosciences of California shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 48,520,000 shares of PACB short. Learn More on Pacific Biosciences of California's current short interest. What is a good short interest ratio for Pacific Biosciences of California? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PACB shares currently have a short interest ratio of 5.0. Learn More on Pacific Biosciences of California's short interest ratio. Which institutional investors are shorting Pacific Biosciences of California? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Pacific Biosciences of California: IMC Chicago LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Pacific Biosciences of California's short interest increasing or decreasing? Pacific Biosciences of California saw a decline in short interest during the month of April. As of April 15th, there was short interest totaling 48,520,000 shares, a decline of 1.1% from the previous total of 49,050,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Pacific Biosciences of California's short interest compare to its competitors? Here is how the short interest of companies compare to Pacific Biosciences of California: Nautilus Biotechnology, Inc. (1.95%), Akoya Biosciences, Inc. (4.74%), Quanterix Co. (3.21%), Harvard Bioscience, Inc. (1.55%), Seer, Inc. (5.96%), Standard BioTools Inc. (3.05%), Bionano Genomics, Inc. (8.85%), Cytek Biosciences, Inc. (6.29%), Accelerate Diagnostics, Inc. (2.90%), EyePoint Pharmaceuticals, Inc. (13.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Pacific Biosciences of California stock? Short selling PACB is an investing strategy that aims to generate trading profit from Pacific Biosciences of California as its price is falling. PACB shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Pacific Biosciences of California? A short squeeze for Pacific Biosciences of California occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PACB, which in turn drives the price of the stock up even further. How often is Pacific Biosciences of California's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PACB, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Nautilus Biotechnology Short Squeeze Akoya Biosciences Short Squeeze Quanterix Short Squeeze Harvard Bioscience Short Squeeze Seer Short Squeeze Standard BioTools Short Squeeze Bionano Genomics Short Squeeze Cytek Biosciences Short Squeeze Accelerate Diagnostics Short Squeeze EyePoint Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PACB) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressGreat Crypto BullWeiss RatingsJeff Bezos Just Humiliated Elon MuskInvestorPlace